4//SEC Filing
Miller Ann Calby 4
Accession 0001055726-23-000034
CIK 0001055726other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:50 PM ET
Size
11.4 KB
Accession
0001055726-23-000034
Insider Transaction Report
Form 4
Miller Ann Calby
Director
Transactions
- Exercise/Conversion
Restricted Stock Unit
2023-05-16−19,000→ 0 total→ Common Stock (19,000 underlying) - Exercise/Conversion
Common Stock
2023-05-16+19,000→ 66,534 total - Award
Common Stock Options
2023-05-15+35,000→ 35,000 totalExercise: $0.77Exp: 2033-05-15→ Common Stock (35,000 underlying) - Award
Restricted Stock Unit
2023-05-15+26,000→ 26,000 total→ Common Stock (26,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.
- [F2]This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy.
- [F3]Options to vest 100% on May 15, 2024.
- [F4]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001771423
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:50 PM ET
- Size
- 11.4 KB